ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology

Stock Information for ImmunoPrecise Antibodies Ltd.

Loading

Please wait while we load your information from QuoteMedia.